A high-throughput assay for a human telomerase protein-human telomerase RNA interaction

Analytical Biochemistry

Volumn 353, Issue 1, 2006, Pages 75-82

  Keppler, Brian R ^a   Jarstfer, Michael B ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

High throughput screen; Scintillation proximity assay; Telomerase; Telomerase assemblage; Telomerase RNA; Telomere

Indexed keywords

CHROMOSOMES; COENZYMES; DISEASES; SCINTILLATION;

ENZYMATIC ACTIVITIES; HIGH-THROUGHPUT ASSAYS; HIGH-THROUGHPUT SCREENS; MULTI-SUBUNIT ENZYMES; STATISTICAL EVALUATION; TELOMERASE; TELOMERE MAINTENANCE; TELOMERES;

RNA;

BIOTIN; RNA; STREPTAVIDIN; SULFUR 35; TELOMERASE;

ACCURACY; ARTICLE; ASSAY; BINDING AFFINITY; HIGH THROUGHPUT SCREENING; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; PURIFICATION; SCINTILLATION; STATISTICAL ANALYSIS; VACUUM;

EID: 33646353663     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2006.03.027     Document Type: Article

References (53)

1. Rhodes D., Fairall L., Simonsson T., Court R., and Chapman L. Telomere architecture. EMBO Rep. 3 (2002) 1139-1145
2. Olovnikov A.M. A theory of marginotomy: the incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol. 41 (1973) 181-190
3. Watson J.D. Origin of concatemeric T7 DNA. Nat. New Biol. 239 (1972) 197-201
4. Broccoli D., Young J.W., and de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc. Natl. Acad. Sci. USA 92 (1995) 9082-9086
5. Hiyama K., Hirai Y., Kyoizumi S., Akiyama M., Hiyama E., Piatyszek M.A., Shay J.W., Ishioka S., and Yamakido M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 155 (1995) 3711-3715
6. Wright W.E., Piatyszek M.A., Rainey W.E., Byrd W., and Shay J.W. Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet. 18 (1996) 173-179
7. Ramirez R.D., Wright W.E., Shay J.W., and Taylor R.S. Telomerase activity concentrates in the mitotically active segments of human hair follicles. J. Invest. Dermatol. 108 (1997) 113-117
8. Cong Y.S., Wright W.E., and Shay J.W. Human telomerase and its regulation. Microbiol. Mol. Biol. Rev. 66 (2002) 407-425
9. Meyerson M., Counter C.M., Eaton E.N., Ellisen L.W., Steiner P., Caddle S.D., Ziaugra L., Beijersbergen R.L., Davidoff M.J., Liu Q., Bacchetti S., Haber D.A., and Weinberg R.A. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90 (1997) 785-795
10. Nakamura T.M., Morin G.B., Chapman K.B., Weinrich S.L., Andrews W.H., Lingner J., Harley C.B., and Cech T.R. Telomerase catalytic subunit homologs from fission yeast and human. Science 277 (1997) 955-959
11. Feng J., Funk W.D., Wang S.S., Weinrich S.L., Avilion A.A., Chiu C.P., Adams R.R., Chang E., Allsopp R.C., Yu J., Le S., West M.D., Harley C.B., Andrews W.H., Greider C.W., and Villeponteau B. The RNA component of human telomerase. Science 269 (1995) 1236-1241
12. Chen J.L., Blasco M.A., and Greider C.W. Secondary structure of vertebrate telomerase RNA. Cell 100 (2000) 503-514
13. Chen J.L., Opperman K.K., and Greider C.W. A critical stem-loop structure in the CR4-CR5 domain of mammalian telomerase RNA. Nucleic Acids Res. 30 (2002) 592-597
14. Chen J.L., and Greider C.W. Determinants in mammalian telomerase RNA that mediate enzyme processivity and cross-species incompatibility. EMBO J. 22 (2003) 304-314
15. Mitchell J.R., and Collins K. Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase. Mol. Cell 6 (2000) 361-371
16. Tesmer V.M., Ford L.P., Holt S.E., Frank B.C., Yi X., Aisner D.L., Ouellette M., Shay J.W., and Wright W.E. Two inactive fragments of the integral RNA cooperate to assemble active telomerase with the human protein catalytic subunit (hTERT) in vitro. Mol. Cell. Biol. 19 (1999) 6207-6216
17. Leeper T.C., and Varani G. The structure of an enzyme-activating fragment of human telomerase RNA. RNA 11 (2005) 394-403
18. Hahn W.C., Stewart S.A., Brooks M.W., York S.G., Eaton E., Kurachi A., Beijersbergen R.L., Knoll J.H., Meyerson M., and Weinberg R.A. Inhibition of telomerase limits the growth of human cancer cells. Nat. Med. 5 (1999) 1164-1170
19. Djojosubroto M.W., Chin A.C., Go N., Schaetzlein S., Manns M.P., Gryaznov S., Harley C.B., and Rudolph K.L. Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma. Hepatology 42 (2005) 1127-1136
20. White L.K., Wright W.E., and Shay J.W. Telomerase inhibitors. Trends Biotechnol. 19 (2001) 114-120
21. Saretzki G. Telomerase inhibition as cancer therapy. Cancer Lett. 194 (2003) 209-219
22. Zhang X., Mar V., Zhou W., Harrington L., and Robinson M.O. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev. 13 (1999) 2388-2399
23. Yokoyama Y., Takahashi Y., Shinohara A., Wan X., Takahashi S., Niwa K., and Tamaya T. The 5′-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity. Biochem. Biophys. Res. Commun. 273 (2000) 316-321
24. Hao Z.M., Luo J.Y., Cheng J., Wang Q.Y., and Yang G.X. Design of a ribozyme targeting human telomerase reverse transcriptase and cloning of its gene. World J. Gastroenterol. 9 (2003) 104-107
25. Shay J.W., and Wright W.E. Telomerase: a target for cancer therapeutics. Cancer Cell 2 (2002) 257-265
26. Pitts A.E., and Corey D.R. Inhibition of human telomerase by 2′-O-methyl-RNA. Proc. Natl. Acad. Sci. USA 95 (1998) 11549-11554
27. Elayadi A.N., Demieville A., Wancewicz E.V., Monia B.P., and Corey D.R. Inhibition of telomerase by 2′-O-(2-methoxyethyl) RNA oligomers: effect of length, phosphorothioate substitution, and time inside cells. Nucleic Acids Res. 29 (2001) 1683-1689
28. Asai A., Oshima Y., Yamamoto Y., Uochi T.A., Kusaka H., Akinaga S., Yamashita Y., Pongracz K., Pruzan R., Wunder E., Piatyszek M., Li S., Chin A.C., Harley C.B., and Gryaznov S. A novel telomerase template antagonist (GRN163) as a potential anticancer agent. Cancer Res. 63 (2003) 3931-3939
29. Norton J.C., Piatyszek M.A., Wright W.E., Shay J.W., and Corey D.R. Inhibition of human telomerase activity by peptide nucleic acids. Nat. Biotechnol. 14 (1996) 615-619
30. Corey D.R. Telomerase inhibition, oligonucleotides, and clinical trials. Oncogene 21 (2002) 631-637
31. Sun D., Thompson B., Cathers B.E., Salazar M., Kerwin S.M., Trent J.O., Jenkins T.C., Neidle S., and Hurley L.H. Inhibition of human telomerase by a G-quadruplex-interactive compound. J. Med. Chem. 40 (1997) 2113-2116
32. Read M.A., Wood A.A., Harrison J.R., Gowan S.M., Kelland L.R., Dosanjh H.S., and Neidle S. Molecular modeling studies on G-quadruplex complexes of telomerase inhibitors: structure-activity relationships. J. Med. Chem. 42 (1999) 4538-4546
33. Read M., Harrison R.J., Romagnoli B., Tanious F.A., Gowan S.H., Reszka A.P., Wilson W.D., Kelland L.R., and Neidle S. Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors. Proc. Natl. Acad. Sci. USA 98 (2001) 4844-4849
34. Harrison R.J., Gowan S.M., Kelland L.R., and Neidle S. Human telomerase inhibition by substituted acridine derivatives. Bioorg. Med. Chem. Lett. 9 (1999) 2463-2468
35. Han H., Langley D.R., Rangan A., and Hurley L.H. Selective interactions of cationic porphyrins with G-quadruplex structures. J. Am. Chem. Soc. 123 (2001) 8902-8913
36. Shi D.F., Wheelhouse R.T., Sun D., and Hurley L.H. Quadruplex-interactive agents as telomerase inhibitors: Synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase. J. Med. Chem. 44 (2001) 4509-4523
37. Han H., Cliff C.L., and Hurley L.H. Accelerated assembly of G-quadruplex structures by a small molecule. Biochemistry 38 (1999) 6981-6986
38. Rangan A., Fedoroff O.Y., and Hurley L.H. Induction of duplex to G-quadruplex transition in the c-myc promoter region by a small molecule. J. Biol. Chem. 276 (2001) 4640-4646
39. Fedoroff O.Y., Salazar M., Han H., Chemeris V.V., Kerwin S.M., and Hurley L.H. NMR-based model of a telomerase-inhibiting compound bound to G-quadruplex DNA. Biochemistry 37 (1998) 12367-12374
40. Koeppel F., Riou J.F., Laoui A., Mailliet P., Arimondo P.B., Labit D., Petitgenet O., Helene C., and Mergny J.L. Ethidium derivatives bind to G-quartets, inhibit telomerase, and act as fluorescent probes for quadruplexes. Nucleic Acids Res. 29 (2001) 1087-1096
41. Keppler B.R., and Jarstfer M.B. Inhibition of telomerase activity by preventing proper assemblage. Biochemistry 43 (2004) 334-343
42. Dominick P.K., Keppler B.R., Legassie J.D., Moon I.K., and Jarstfer M.B. Nucleic acid-binding ligands identify new mechanisms to inhibit telomerase. Bioorg. Med. Chem. Lett. 14 (2004) 3467-3471
43. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., and Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science 266 (1994) 2011-2015
44. Wright W.E., Shay J.W., and Piatyszek M.A. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity, and sensitivity. Nucleic Acids Res. 23 (1995) 3794-3795
45. Francis R., and Friedman S.H. A rapid direct telomerase assay method using 96-well streptavidin plates. BioTechniques 32 (2002) 1154-1160
46. Francis R., and Friedman S.H. An interference-free fluorescent assay of telomerase for the high-throughput analysis of inhibitors. Anal. Biochem. 323 (2003) 65-73
47. Kha H., Zhou W., Chen K., Karan-Tamir B., San Miguel T., Zeni L., Kearns K., Mladenovic A., Rasnow B., Robinson M., and Wahl R.C. A telomerase enzymatic assay that does not use polymerase chain reaction, radioactivity, or electrophoresis. Anal. Biochem. 331 (2004) 230-234
48. Atha D.H., Miller K., Sanow A.D., Xu J., Hess J.L., Wu O.C., Wang W., Srivastava S., and Highsmith W.E. High-throughput analysis of telomerase by capillary electrophoresis. Electrophoresis 24 (2003) 109-114
49. Savoysky E., Akamatsu K., Tsuchiya M., and Yamazaki T. Detection of telomerase activity by combination of TRAP method and scintillation proximity assay (SPA). Nucleic Acids Res. 24 (1996) 1175-1176
50. Bosworth N., and Towers P. Scintillation proximity assay. Nature 341 (1989) 167-168
51. Zhang J.H., Chung T.D., and Oldenburg K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4 (1999) 67-73
52. Yi X., Tesmer V.M., Savre-Train I., Shay J.W., and Wright W.E. Both transcriptional and posttranscriptional mechanisms regulate human telomerase template RNA levels. Mol. Cell. Biol. 19 (1999) 3989-3997
53. Hamilton S.E., Simmons C.G., Kathiriya I.S., and Corey D.R. Cellular delivery of peptide nucleic acids and inhibition of human telomerase. Chem. Biol. 6 (1999) 343-351